Our finding that SARS-CoV-2 spike protein suppresses ACE2 and type I interferon expression in macaque BALs highlights the potential protective role in combating SARS-CoV-2 and strengthens the basis for using type I IFNs as therapies in COVID-19 patients. This evidence concerns the gene ACE2 and COVID-19.